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1.1 Introduction 
Curcuma heyneana Valeton & Zijp is one of the medicinal plants native to Indonesia 
and widely found in Java Island. It belongs to the Zingiberaceae family and includes of the 
species of the Curcuma genus, which has local name Temu giring. [1] It is a perennial, 
herbaceous plant, with 0.3-0.5 m height, producing pseudo stems from a much branched and 
elongated rhizome. The pseudo stems are made up of several leaves whose blades can be 
17-42 cm long and 7-13 cm wide. The rhizomes are aromatic, pale yellow and taste bitter. It 
grows down with square branches. The leaves are all in green. The flower comes out from the 
side of the pseudo stem with red color on the edge of the crown. Its protective leaves have 
sharp edges. [2] The picture of C. heyneana as portrayed in fig. 1 
 
Figure 1. Curcuma heyneana 
(https://www.biodiversitylibrary.org/name/Curcuma_heyneana#) 
It is used traditionally as anthelmintic, and also to treat diseases such as cancer, 
inflammatory conditions, and skin diseases. For preventive purpose, it’s also applied for skin 
treatment as skin scrub, to make women skin’s color brighter.  
The rhizomes of C. heyneana contained ca.0.43% oil, classified as sesquiterpenes 
(87.3%), diterpenes (4.8%), and monoterpenes (3.0%). [3]. Isolation of the essential oil from 
the rhizomes of C. heyneana has been described by Firman et al. [4]. It consisted 
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sesquiterpenoids and also a diterpene, (E)- labda-8(17), 12-diene-15,16-dial. While Azis 
Saifudin et al., obtained germacranes, guaianes, spirolactones together with other 
sesquiterpenes and also labdane-type diterpenes. [5]  
In this study, we reported phytochemical investigation of ethyl acetate extract of 
C.heyneana through bioassay guided isolation procedure. It leaded to the isolation of 15 
known compounds including terpenoids (guaiane-type sesquiterpenes and labdane-type 
diterpenes), two compounds fatty acids, two compounds curcuminoids and also adenosine, a 
purine nucleoside. All isolated compounds were separated by assorted of chromatographic 
methods, whereas the structures of these compounds were determined by spectroscopic 
analyses. We also examined all isolated compounds against parasite Leishmania major. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
㻌
㻌
1.2 Extraction and Isolation of Chemical Constituent 
C. heyneana rhizomes were attained from a cultivated region in East Java, Indonesia. 
A voucher specimen was deposited in the Herbarium of Hiroshima University (KLN 
CH032015). The rhizomes (6 kg) were washed and cut into pieces. It was dried using at 40 °C 
for 72 hours, followed by milling it into powder. Ethanolic extract was obtained by macerating 
100 g powder using 70% ethanol (1:10, w/v) to give extract (606.3 g). About 266.0 g of them 
was suspended in water and partitioned with ethyl acetate three times producing ethyl acetate 
extract (167.5 g). After that, the water layer being partitioned with 1-butanol generating 17.6 g 
extract. The obtained extracts were examined its activity against parasite L. major. From figure 
2, it showed that ethanol and ethyl acetate extracts had the highest inhibitory activity, while 
1-butanol extract exhibited no activity. Based on bioassay guided fractionation procedure, 
ethyl acetate extract was selected to be proceeded furthermore. 
 
Figure 2. Inhibitory activity of C. heyneana extracts 
About 50.0 g ethyl acetate extract was separated on a silica gel open column 
chromatography (CC) and eluting with increasing amount of MeOH in CHCl3 (20:1, 10:1, 
7:1, 5:1, 3:1, 1:1, and 100% MeOH, 500 mL each), generating nine fractions. Fraction II 
(20.9 g) was subjected to octadesyl silica gel (ODS) open column chromatography (CC) with 
a linear gradient of 10% aq. MeOH, from 20%MeOH to 100% MeOH, (1.2 L each), leading 
to nine fractions (f.1-f.9).  
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The fraction 1 (1.7 g) was purified by HPLC using 20% aq. acetone to give 2 (660 
mg), 3 (340 mg), and 4 (80 mg). The fraction 3 (1.7 mg) was purified by HPLC using 70% aq. 
acetone to give 1 (357 mg) and 5 (700 mg). The fraction 4 (1.3 mg) was purified by HPLC 
using 50% aq. acetone to give 5 (560 mg), 6 (10.0 mg) and 10 (34.7 mg). The fraction 5 (0.7 
mg) was purified by HPLC using 60% aq. acetone to give 6 (77.1 mg) and 11 (27.3 mg). The 
fraction 6 (0.5 mg) was purified by HPLC using 70% aq. acetone to give 9 (70 mg) and 25 
(91.9 mg). The fraction 7 (1.0 mg) was purified by HPLC using 80% aq. acetone to give 7 
(10.0 mg), 8 (45.9 mg), 12 (100 mg), and 24 (73 mg).  
Fraction VI (1.7 g) was subjected to ODS open CC with a linear gradient of 10% aq. 
MeOH, from 20%MeOH to 100% MeOH, (300 ml each), leading to nine fractions (f.1-f.9). 
The fraction 1 (0.2 g) was purified by HPLC using 20% aq. MeOH to give 13 (3.6 mg). The 
chart of extraction and isolation of chemical constituents of C. heyneana extract as described 
in fig. 2. 
 
Figure 3. Extraction and isolation of C. heyneana 
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1.3 Structural Elucidation of Isolated Compounds 
The ethyl acetate extract from ethanolic extract of C. heyneana rhizomes was 
fractionated by Silica gel and ODS open CC, then further purified by HPLC to provide 15 
known compounds (fig. 4). The compounds were identified as procurcumenol (1), aerugidiol 
(2), zedoarondiol (3), isozedoarondiol (4), curcumenol (5), 4-epi-curcumenol (6), 
octadecatrienoic acid (7), eicosadienoic acid (8), curcumin (9), gingerol (10), curcuzedoalide 
(11), zerumin A (12), adenosine (13), 14,15,16-trinorlabda-diene-13-oic acid (24) and 
labdan-8 (17)-dien-14,15,16-triol (25). 
Figure 4. Isolated compounds of C. heyneana 
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1.4 Bioactivity examination of Isolated Compounds 
Leishmaniasis is one of neglected-tropical diseases (NTD) categorized by WHO, 
which is instigated by the protozoan Leishmania parasite, through transmission by the bite of 
certain species of sandflies. As per October 2018, about 60% endemic countries have been 
reported by World Health Organization (WHO). The most common leishmaniasis is 
cutaneous leishmaniases (CL), and Leishmania major is one of species which caused that 
disease. It is estimated up to 1 million new cases and about 26.000 to 65.000 mortality cases 
arise, per annum. The available medicines to treat this disease are limited and have many side 
effect such as hepatotoxic, cardiotoxic, ototoxic and nephotoxic [6,7]. 
The inhibitory activity of isolated compounds of C. heyneana extract is illustrated in 
fig. 5. Compound 6, 7, 8, 9, 10, 11, 12, 24 and 25 showed potential activity against L. major 
parasite. While compound 1, 2, 3, 4, 5 and 13 exhibited weak activity against L. major. The 
highest inhibitory activity against L major parasite was sesquiterpene Curcuzeoalide (11) 
with the IC50 value of 4.53 ± 2.63 μg/mL, which has better activity compared with the 
positive control, Miltefosine (IC50 7.47 ± 0.30 μg/mL) as showed in table 1. 
 
Figure 5. L. major inhibitory activity of isolated compound 
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In this study, we were also evaluating the cytotoxicity of isolated compounds against 
human lung cancer cell, A549. The growth inhibitory activity (IC50) of isolated compounds of 
C. heyneana extract against as summarized in table 1. 
Table 1. Anti-leishmania activity of isolated compounds from C. heyneana extract. 
Isolated 
Compound 
L. major 
IC50 (μg/ml) 
A549  
IC50 (μg/mL) 
SI 
6 33.23 ± 4.11 >100 3.01 
7 30.96 ± 3.46 15.70 ± 3.33 0.51 
8 32.65± 1.45 62.96± 3.88 1.93 
9 36.60 ± 1.35 15.33 ± 3.65 0.42 
10 55.93 ± 2.85 22.45 ±  6.03 0.40 
11 4.53 ± 2.63 27.95 ±  1.45 6.17 
12 14.98 ± 1.88 32.22 ±  1.68 2.15 
24 30.91 ±  1.90 42.14 ± 3.51 1.36 
25 31.47 ± 1.23 16.01 ± 1.00 0.51 
Etoposide n.d 7.58±0.06 n.d 
Miltefosine 7.47 ± 0.30 n.d n.d 
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The selectivity index (SI) is a relative amount that assesses the chance between 
citotoxicity and anti leishmania activity. Supposedly, the higher SI ratio, the safer and more 
effective a medicine would be during medication for treating leishmaniasis. From table 1, the 
sesquiterpene Curcuzeoalide (11) has the highest SI value (6.17), means that this compound 
is potential to be developed furthermore as anti leishmania candidate. 
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1.5 Experimental Section 
1.5.1. General Methods 
Optical rotations were determined on a JASCO P-1030 digital polarimeter. NMR 
measurements were established on a Bruker Ultrashield 600 spectrometer. HR-ESI-MS data 
were performed with a LTQ Orbitrap XL mass spectrometer. Column chromatography (CC) 
was carried out on silica gel 60 (E. Merck, Darmstadt, Germany), and octadecyl silica (ODS) 
gel (Cosmosil 75C18-OPN (Nacalai Tesque, Kyoto, Japan; Φ= 35 mm, L = 350 mm). HPLC 
was performed on ODS gel (Inertsil ODS-3, GL-science, Φ=6 mm, 250 mm) and the solvent 
eluation was observed by refractive index detector with a Jasco RI-930 intelligent detector and 
a Jasco PU-1580 intelligent pump. All chemicals were purchased from Wako Pure Chemical 
Industries, Ltd. (Osaka, Japan) and TCI (Tokyo, Japan). 
1.5.2. Isolated compounds 
Procurcumenol (1) 
Colorless oil, [α]D24.4 +206.0° (c = 0.61, CHCl3); 1H-NMR (600 MHz, methanol-d4, δ): 1.22 
(3H, s), 1.73 (3H, s), 1.78 (3H, s), 1.86 – 1.88 (1H, overlapped), 1.85-1.90 (2H, overlapped), 
1.92 (3H, s), 1.98-2.03 (2H, m), 2.21-2.28 (2H, m), 2.44-2.48 (1H, m), 5.85 (1H, q, J = 1.3 Hz). 
13C-NMR (151 MHz, methanol-d4, δ): 21.3, 22.6, 23.6, 24.3, 28.0, 29.6, 40.5, 51.7, 55.2, 80.8, 
129.5, 137.7, 137.7, 4, 159.2, 201.6. HRESIMS (positive ion) m/z: 257.1512 [M+Na]+ (calcd 
for C15H22O2Na: 257.1512).The obtained data were similar with the references [8,9]. 
Aerugidiol (2) 
Colorless oil, [α]D24.4 -19.3° (c = 1.55, MeOH); 1H-NMR (600 MHz, methanol-d4, δ): 5.89 (1H, 
d, J = 1.2 Hz), 4.58 (2H, s), 2.75 (1H, dd, J = 14.0, 2.5 Hz), 2.21 – 2.10 (2H, m), 2.02 (3H, s), 
2.01 (3H, s), 1.94-2.00 (3H, m), 1.93 (3H, s), 1.72 (1H, dd, J = 10.5, 6.9 Hz), 1.22 (3H, s). 
13C-NMR (151 MHz, methanol-d4, δ): 22.6, 23.3, 23.5, 23.8, 28.4, 38.3, 38.7, 63.4, 82.0, 84.9, 
130.8, 133. 6, 145.9, 155.6, 197.5. HRESIMS (positive ion) m/z: 273.1465 [M+Na]+ (calcd for 
C15H22O3Na: 273.1461). The obtained data were similar with the literature [10]. 
Zedoarondiol (3) 
Colorless oil, [α]D24.4 -39.4° (c = 7.86, MeOH); 1H-NMR (600 MHz, methanol-d4, δ): 5.30 (2H, 
br.s), 2.99 (1H, d, J = 12.7 Hz), 2.86 (1H, d, J = 14.9 Hz), 2.51 (1H, d, J = 12.7 Hz), 2.05-1.95 
(2H, m), 1.91 (3H, s), 1.86 (3H, s), 1.75-1.65 (4H, m), 1.40 – 1.33 (1H, t, J=12 Hz), 1.17 (3H, 
s), 1.11 (3H, s). 13C-NMR (151 MHz, methanol-d4, δ): 205.5, 143.2, 136.3, 80.5, 73.1, 60.8, 
57.0, 52.8, 40.0, 29.4, 23.2, 22.9, 22.6, 22.4, 20.2.  
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HRESIMS (positive ion) m/z: 273.1465 [M+Na]+ (calcd for C15H22O3Na: 273.1461). The 
obtained data are similar with the reference [11]. 
Isozedoarondiol (4) 
Colorless oil, [α]D24.4 -125° (c = 1.15, MeOH); 1H-NMR (600 MHz, methanol-d4, δ): 4.57 (2H, 
br.s), 3.33 (1H, br. s), 2.82 – 2.76 (1H, m), 2.52 (1H, d, J = 13.9 Hz), 2.31 (1H, d, J = 16.1 Hz), 
2.04 (1H d, s), 2.03 – 1.99 (1H, m), 1.97 (3H, s), 1.93 – 1.89 (1H, m), 1.88 (3H, s), 1.83 – 1.76 
(1H, s), 1.72 (1H, ddd, J = 14.2, 9.7, 4.5 Hz), 1.62 (1H, ddd, J = 24.2, 11.8, 4.6 Hz), 1.39 (3H, 
s), 1.19 (3H, s). 13C-NMR (151 MHz, methanol-d4, δ): 206.2, 144.6, 135.4, 83.12, 73.9, 53.9, 
52.6, 51.2, 49.8, 37.4, 32.7, 28.4, 26.0, 24.8, 23.2, 22.4. HRESIMS (positive ion) m/z: 
275.1620 [M+Na]+ (calcd for C15H24O3Na: 275.1618). The obtained data are similar with the 
literature [11]. 
Curcumenol (5) 
Colorless needles, [α]D24.4 -367.1° (c = 0.7, MeOH); 1H-NMR (600 MHz, methanol-d4, δ): 5.70 
(1H, br.s), 2.69 – 2.62 (1H, m), 2.14 (1H, dd, J = 15.6, 1.1 Hz), 1.96 (3H, m), 1.85 (2H, s), 1.79 
(3H, s), 1.64 (3H, s), 1.59 (3H, s), 1.53 – 1.46 (1H, m), 1.01 (3H, d, J = 6.6 Hz). 13C-NMR (151 
MHz, methanol-d4, δ): 139.4, 138.1, 127.5, 122.4, 102.6, 86.6, 52.4, 41.4, 38.2, 32.3, 28.7, 22.5, 
21.1, 19.2, 12.3. HRESIMS (positive ion) m/z: 257.1510 [M+Na]+ (calcd for C15H22O2Na: 
257.1512). The obtained data are similar with the references [4, 12]. 
4-Epi-curcumenol (6) 
yellowish amorphous solid, [α]D17.9 +20.8° (c = 0.76, MeOH); 1H-NMR (600 MHz, 
methanol-d4, δ): 5.90 – 5.58 (1H, m), 2.71 – 2.63 (1H, m), 2.23 (1H, d, J = 15.5 Hz, 1H), 2.17 – 
2.12 (1H, m), 2.09 – 2.01 (3H, m), 1.78 (3H, s), 1.66 (3H, s), 1.60 (s, 3H), 1.50 (1H, m), 1.38 – 
1.32 (m, 1H), 0.98 (3H, d, J = 7.3 Hz). 13C-NMR (151 MHz, methanol-d4, δ): 139.0, 137.9, 
127.8, 122.6, 102.3, 88.7, 50.0, 42.9, 38.6, 32.7, 29.5, 22.4, 21.2, 19.3, 17.2. HRESIMS 
(positive ion) m/z: 257.1509 [M+Na]+ (calcd for C15H22O2Na: 257.1512). The obtained data 
are similar with the references [13]. 
9-11-13-Octadecatrienoic acid (α-eleostearic acid) (7) 
white amorphous solid, 1H-NMR (600 MHz, methanol-d4, δ): 5.40 – 5.37 (1H, m), 5.36 (1H, dd, 
J = 8.4, 1.5 Hz), 5.35 (1H, d, J = 8.1 Hz), 5.34 (1H, d, J = 15.4 Hz), 5.32 (1H, d, J = 15.4 Hz), 
5.31 – 5.28 (1H, m), 2.81 (3H, t, J = 5.7 Hz), 2.28 (3H, t, J = 7.4 Hz), 2.15 – 2.03 (2H, m), 1.60 
(d, J = 1.4 Hz, 4H), 1.35 (dd, J = 49.1, 27.5 Hz, 10H), 0.97 (3H, t, J = 7.5 Hz). 13C-NMR (151 
MHz, methanol-d4, δ): 177.9, 132.7, 131.1, 129.2, 129.1, 128.8, 128.2, 35.0, 30.6, 30.2, 30.1, 
30.0, 28.1, 26.5, 26.4, 26.0, 21.5, 14.6. HRESIMS (positive ion) m/z: 279.1588 [M+H]+ (calcd 
for C18H31O2: 279.2319). The obtained data are similar with the references [14,15]. 
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11-hydroxy-12,14-Eicosadienoic acid (coriolic acid) (8) 
white amorphous solid, 1H-NMR (600 MHz, methanol-d4, δ): 6.48 (1H, dd, J = 15.2, 11.1 Hz), 
5.97 (1H, t, J = 11.0 Hz), 5.61 (1H, dd, J = 15.2, 6.8 Hz), 5.44 – 5.37 (1H, m), 4.08 (1H, dd, J = 
13.1, 6.5 Hz), 3.94 – 3.77 (3H, m), 2.65 (1H, s), 2.27 (5H, t, J = 7.4 Hz), 2.18 (3H, dd, J = 14.2, 
7.3 Hz), 1.35-1.25 (11H, m), 0.93 – 0.87 (3H, m). 13C-NMR (151 MHz, methanol-d4, δ): 177.8, 
137.2, 133.0, 129.3, 126.5, 73.3, 38.3, 34.9, 32.5, 30.4, 30.3, 30.2, 30.1, 28.5, 26.4, 26.0, 23.6, 
14.4. HRESIMS (positive ion) m/z: 319.2237 [M+Na]+ (calcd for C18H33O3Na: 319.2244). The 
obtained data are similar with the references [14,16]. 
Curcumin (9) 
yellow crystalline, 1H-NMR (600 MHz, methanol-d4, δ): 7.57 (1H, d, J = 15.9 Hz), 7.49 (1H, d, 
J = 15.7 Hz), 7.22 (1H, d, J = 15.2 Hz, 3H), 7.10 (1H, d, J = 15.5 Hz), 6.98 (1H, d, J = 16.2 Hz), 
6.84 – 6.81 (4H, m), 6.77 (1H, br.s), 6.68 (2H, d, J = 8.2 Hz), 4.58 (2H, br. s), 3.91 (6H, s). 
13C-NMR (151 MHz, methanol-d4, δ): 184.9, 184.7, 150.4, 149.4, 142.1, 141.9, 131.2, 130.4, 
128.6, 128.0, 124.1, 122.3, 122.0, 116.9, 116.9, 116.6, 111.8, 109.6, 56.5, 56.5. HRESIMS 
(positive ion) m/z: 369.1318 [M+H]+ (calcd for C21H21O6: 369.1333). The obtained data are 
similar with the literature [17]. 
3,5-Diacetoxy-1,7-bis-(4’-hydroxy-3’-methoxyphenyl)-heptane (Gingerol) (10) 
Colorless oil, 1H-NMR (600 MHz, methanol-d4, δ): 6.95 (2H, d, J = 8.4 Hz), 6.70 (2H, dd, J = 
4.9, 2.0 Hz), 6.66 (1H, d, J = 8.0 Hz), 6.60 – 6.54 (2H, m), 6.45 (1H, dd, J = 8.0, 2.2 Hz), 6.28 
(2H, s), 3.82 (6H, s), 2.58 – 2.39 (4H, m), 1.98 (1H, br.s), 1.97 (4H, q, J = 7.4 Hz), 1.95 (6H, s), 
1.87 (1H, m). 13C-NMR (151 MHz, methanol-d4, δ): 172.7, 172.7, 148.8, 146.1, 145.5, 144.3, 
134.2, 134.1, 121.8, 120.7, 116.4, 116.2, 116.2, 113.2, 72.4, 72.4, 56.4, 56.4, 39.4, 37.0, 36.9, 
31.8, 31.8, 21.1, 21.1. HRESIMS (positive ion) m/z: 461.2130 [M+H]+ (calcd for C25H33O8: 
461.2170). The obtained data are similar with the references [18, 19]. 
Curcuzedoalide (11) 
white amorphous solid, [α]D18.6 +24.8° (c = 1.25, CHCl3); 1H-NMR (600 MHz, methanol-d4, δ): 
6.10 (1H, s), 5.92 (1H, d, J = 1.4 Hz), 5.58 (1H, d, J = 1.3 Hz), 3.93 – 3.75 (2H, m), 3.34 (1H, 
d, J = 6.2 Hz), 2.88 (1H, dd, J = 11.2, 6.5 Hz), 2.84 (1H, d, J = 14.0 Hz), 2.30 – 2.20 (1H, m), 
2.20 – 2.10 (1H, m), 1.91 (3H, d, J = 1.3 Hz), 1.78 (3H, s), 1.49 – 1.44 (1H, m), 1.09 (3H, d, J 
= 6.8 Hz). 13C-NMR (151 MHz, methanol-d4, δ): 201.5, 166.5, 164.5, 146.4, 128.3, 122.3, 
114.4, 92.6, 46.3, 46.2, 43.3, 32.2, 31.4, 22.7, 17.6, 12.2. HRESIMS (positive ion) m/z: 
271.1322 [M+Na]+ (calcd for C15H20O3Na: 257.1305). The obtained data are similar with the 
references [20]. 
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Zerumin A (12) 
yellowish oil, [α]D17.0 +6.8° (c = 1.7, ethanol); 1H-NMR (600 MHz, methanol-d4, δ): 9.32 (1H, 
s), 6.74 (1H, t, J = 6.4 Hz), 4.86 (1H, s), 4.48 (1H, s), 2.60 (2H, ddd, J = 16.8, 5.9, 2.9 Hz,), 2.49 
– 2.39 (1H, m), 2.00 (1H, d, J = 10.7 Hz), 1.90 – 1.70 (4H, m), 1.70 – 1.48 (4H, m), 1.48 – 1.10 
(5H, m), 0.90 (3H, s), 0.85 (3H, s), 0.77 (3H, s). 13C-NMR (151 MHz, methanol-d4, δ): 195.5, 
173.8, 160.7, 149.4, 137.9, 108.6, 57.5, 56.5, 43.1, 40.5, 40.2, 38.9, 34.4, 34.1, 30.2, 25.6, 25.3, 
22.3, 20.3, 14.9. HRESIMS (positive ion) m/z: 341.2079 [M+Na]+ (calcd for C20H30O3Na: 
341.2087). The obtained data are similar with the references [21]. 
Adenosine (13) 
White amorphous solid, [α]D17.0 -17.1° (c = 0.24, methanol); 1H-NMR (600 MHz, pyridine-d5, 
δ): 8.63 (1H, s), 8.38 (1H, s), 6.74 (1H, d, J = 5.9 Hz), 5.51 (1H, t, J = 5.4 Hz,), 5.09 (1H, m), 
4.78 (1H, m), 4.33 (1H, dd, J = 12.3, 2.6 Hz), 4.16 (1H, dt, J = 12.3, 2.5 Hz). 13C-NMR (151 
MHz, pyridine-d5, δ): 158, 2, 153.8, 150.4, 121.9, 141.0, 91.3, 88, 3, 76.0, 72.9, 63.5. 
HRESIMS (positive ion) m/z: 268.1041 [M+H]+ (calcd for C10H14O4N5: 268.1040). The 
obtained data are similar with the references [22]. 
14,15,16-Trinorlabda-8(17), 11-diene-13-oic acid (24) 
Colorless oil, [α]D18.3 +16° (c = 4.0, CHCl3); 1H-NMR (600 MHz, methanol-d4, δ): 7.02 (1H, dd, 
J = 15.5, 10.5 Hz), 5.79 (1H, d, J = 15.5 Hz), 4.78 (1H, br.s), 4.41 (1H, br.s), 2.49 (1H, d, J = 
12.0 Hz), 2.20 – 1.98 (2H, m), 1.82 – 1.70 (1H, m), 1.70 – 1.55 (5H, m), 1.51 – 1.24 (3H, m), 
0.91 (3H, s), 0.90 (3H, s), 0.87 (3H, s). 13C-NMR (151 MHz, methanol-d4, δ): 169.5, 149.9, 
149.3, 125.0, 109.1, 61.6, 55.6, 43.2, 41.8, 40.1, 37.6, 34.4, 34.0, 24.4, 22.4, 20.0, 15.5. 
HRESIMS (negative ion) m/z: 261.1863 [M-H]- (calcd for C17H25O2: 261.1849). The obtained 
data are similar with the references [23]. 
Labdan-8 (17)-dien-14,15,16-triol (25) 
White amorphous solid, [α]D24.4 +5.3° (c = 1.16, CHCl3); 1H-NMR (600 MHz, methanol-d4, δ): 
5.50 (1H, t, J = 6.5 Hz), 4.69 (1H, dd, J = 7.5, 4.6 Hz), 4.53 (1H, d, J = 11.0 Hz), 4.16 – 4.10 
(1H, m), 4.02 – 3.96 (1H, m), 3.68 – 3.62 (1H, m), 3.59 – 3.53 (1H, m), 2.24 – 1.96 (4H, m), 
1.93 – 1.47 (5H, m), 1.48 – 1.28 (3H, m), 1.31 – 1.04 (3H, m), 0.89 (3H, s), 0.84 (3H, s), 0.75 
(3H, s). 13C-NMR (151 MHz, methanol-d4, δ): 149.5, 138.4, 132.5, 108.3, 72.0, 66.2, 64.3, 58.7, 
56. 8, 43.3, 40.7, 40.3, 39.2, 34.5, 34.1, 25.4, 23.2, 22.2, 20.4, 15.0. HRESIMS (positive ion) 
m/z: 345.2400 [M+Na]+ (calcd for C20H34O3Na: 345.2400). The obtained data are similar with 
the references [24]. 
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1.5.3. Bioassay examination of isolated compounds 
1.5.3.1. Antileishmania assay 
The leishmanicidal activities of isolated compounds were conducted using MTT assay. In 
a 96-well micro titration plate, 1 μL of sample solutions in DMSO (1% as final concentration) 
and L. major cells (1×105 cells/well) in 99 μL medium were added to each well. Then being 
incubated for 72 h in a CO2 incubator at 25 °C. M-199 medium, supplemented with 10% 
heat-inactivated fetal bovine serum (FBS) and 100 μg/ml of kanamycin was used as the cell 
culture medium. After that, a 100 μL of MTT solution was added to each well and continued 
the incubation for another 8 hours. The absorbance of the DMSO dissolved-formazan products 
was recorded using a microplate reader at λ540 nm. IC50 was observed as the concentration of 
the compounds to inhibit 50% L. major parasite. The equation (1) was used to estimate % 
inhibition of the samples: [25]. 
 
(1) 
 
1.5.3.2. A549 Growth Inhibition Assay 
This experiment was performed using A549 cell line by MTT 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method. Procedure of this 
assay was referred to the reference without any modification. Doxorubicin was used as a 
positive control. All the tested compounds were prepared in DMSO solution. The cell growth 
inhibition was calculated using the following equation 1. IC50 was determined as the 
concentration of sample to inhibit 50% of the growth of cancer cell. The smaller the IC50 
value of the compound compared to the standard compound, the higher activity of the 
compound to inhibit A549 cancer cell [25]. 
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2.1 Introduction 
Natural products have been acknowledged as a main resource in drug development 
due to their structural assortment and complexity. It’s also frequently offering greatly definite 
biological activity. It has been informed that the employment of natural products and/or their 
novel structures, with the purpose of finding and extends the drug entity, is yet prosperous and 
satisfactory. For instance, from the 1940s up to 2014, of the 175 small molecules approved as 
anticancer, and about 49% is natural products or directly resulting thence. [26,27]. Therefore, 
natural products and its derivatives are even now beneficial for discovery of drug-lead 
compounds. 
In the last decade or so, it has been introduced an approach to produce bioactive 
compounds via chemical modification of crude natural extracts. This approach is an obvious 
method for altering the chemical composition of crude herbal extracts, which caused changes 
in their biological activity in a negative or positive manner. Some methods such as 
sulfonylation with p-toluene sulfonyl chloride [28,29], ammonolysis with hydrazine 
monohydrate [29,30,31], bromination with bromine [29,32], oxidation with Dess-Martin 
periodinane (DMP), reduction with sodium borohydride, epoxidation with m-chloroperbenzoic 
acid (mCPBA) [33] and methyl(trifluoromethyl)dioxirane then followed by transannulation 
with a Lewis acid catalyst [34], ethanolysis with hydroxylamine hydrochloride [35] to natural 
extracts have been carried out to produce novel or bioactive compounds. 
Alpinia galanga (L.) belongs to family Zingiberaceae, which extensively distributed 
in China, India and Southeast Asian countries include Indonesia. A. galanga is an is a tropical 
plant with an aromatic perennial growing up to 7 m tall. The leaves are lanceolate while the 
flowers are white with pink markings. The rhizome has an aromatic odor while the taste is 
pungent and spicy. The parts of this plant include rhizome, fruit and flowers have been used as 
a spice, flavoring agent, food additives and gastroprotective. The picture of A. galanga as 
portrayed in fig. 6. Traditionally it is being applied for treating dyspepsia and abdominal colic 
pain, motion sickness, and gastralgia [36,37]. Up to now, there are numerous articles about 
pharmacological activities of A. galanga, for instance antialergic [38], anticancer [39-41], 
anti-inflammatory [42], antimicrobial [43-45], antioxidant [45,46], antiamnesic [47], 
antiasthma [48], and also melanogenesis inhibitor [49]. Nevertheless, there is very rare report 
about its activity as anti-leishmanial agent. Thanh Binh Le, et al. screened 37 Vietnamese 
plants, including A. galanga, against Leishmania Mexicana Mexicana (Lmm). They reported 
that A. galanga didn’t’ posses ability in inhibiting Lmm [50]. 
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In this report, a chemical alteration method was conducted concurrently with 
bioactivity-guided isolation of an inactive ethyl acetate extract from A. galanga and 1-butanol 
extract from C. heyneana to generate some new phenylpropanoid analogues (14-17) and a new 
sesquiterpene (30), along with other known compounds (18-23, 26-29). Furthermore, the 
isolated compounds were also being examined against parasite L. major. 
㻌
Figure 6. Alpinia galanga (L) 
(https://www.naturalmedicinefacts.info/plant/alpinia-galanga.html) 
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2.2 Extraction and Isolation of Chemically Converted Extract of A. galanga 
The dried rhizomes of A. galanga (2.0 kg) were extracted with MeOH (3x 1.5 L) at room 
temperature to give MeOH extract. Afterward, this extract was partitioned by solvent 
fractionation with EtOAc/H2O to give EtOAc extract. The ethyl acetate extract was used for 
being treated with dioxirane to produce the chemically converted extract (CCE). Dioxirane is 
powerful reagent for epoxidation, which generated in situ, by reacting acetone with potassium 
peroxomonosulfate [51]. After being quenched and evaporated, HPLC analyses of the CCE 
and original extract were carried out, and followed by biological assay. The antileishmania 
activity of both extracts (original extract and CCE) against promastigotes of L. major was 
conducted by the colorimetric method 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium 
bromide (MTT) assay [52]. Figure 7 exhibited that the inhibitory activity of CCE is 
significantly increased after treating of dioxirane.  
 
Figure 7. Inhibitory activity of A. galanga extracts. 
The chart of extraction and isolation of chemical constituents from CCE of A. galanga 
as described in fig. 8. 
0 
20 
40 
60 
80 
100 
original extract (before 
treatment)
CCE (after treatment)
Inhibitory activity againts L.major
100μg/mL
50μg/mL
25μg/mL
㻌
㻌
Figure 8. Extraction and isolation of CCE from A.galanga 
 
 
 
 
 
 
 
 
 
㻌
㻌
2.3 Structural Elucidation of Isolated Compounds 
By using bio-guided isolation procedure, the CCE of A. galanga was further 
separated by assorted column chromatographies and HPLC to provide compounds A–F 
(14-19). In addition, by referring the NMR data from literatures, the structures of the known 
compounds were named as hydroquinone (20) [53], 4-hydroxy(4-hydroxyphenyl)methoxy)- 
benzaldehyde (21) [54], isocoumarin cis 4-hydroxymelein (22) [55] and (2S, 3S, 6R, 7R, 9S, 
10S)-humulene triepoxide (23) [56]. 
 
Figure 9. Isolated compounds of A. galanga 
Compound 14 was attained as colorless liquid. Its molecular formula was revealed to 
be C10H13O3ClNa from an ion at m/z 239.0446, with characteristic pattern of halide ion (Cl-) 
fragmentation at [M+2] in the HRESIMS. The IR data exhibited bands for hydroxyl group 
(3350 cm-1) and C-Cl stretching bond (850 cm-1) absorption The 1H NMR data (table 2) 
showed the presence of one methoxy group at 3.36 ppm, and para-substituted aromatic rings 
at 7.21 and 6.76 ppm as doublet (J = 8.6Hz) each in 14. The 1H and 13C-NMR data were 
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nearly similar as those of (anti)-2-chloro-3-phenyl-1,3-propandiol. On the basis of the 
coupling constant of H-7 and H-8 (J=5.6Hz), 14 was assigned as threo- compound too, in 
accordance with a reference [57]. 
Table 2. 1H-NMR spectroscopic data for compounds 14-191 
Position 14 15 17 18 16 19 
1       
2,6 7.21 d (8.6) 7.10 d (8.5) 7.19 d (8.4) 7.21 d (8.6) 7.13 d (8.5) 7.21 d (8.6) 
3,5 6.76 d (8.6) 6.77 d (8.5) 6.76 d (8.6) 6.76 d (8.6) 6.78 d (8.5) 6.79 d (8.6) 
4       
7 4.80 d (5.9) 4.19 dd (7.8, 6.1) 4.51 d (6.6) 4.53 d (6.3) 4.08 d (7.3) 4.69 d (8.8) 
7-OCH3  3.14 s   3.19 s  
8 4.22 dd  
(11.1, 5.9) 
2.02 ddt  
(16.5, 11.9, 5.1) 
3.74 td  
(6.6, 3.4) 
3.84 td  
(6.5, 3.4) 
3.74 ddd  
(7.4, 5.8, 3.2) 
3.89 ddd  
(8.6, 5.6, 2.8) 
  1.78 m     
9 
3.61 m 
3.44 dt  
(9.4, 6.5) 
3.15 dd 
(10.1, 6.2) 
3.44 dd  
(10.1, 6.7) 
3.08 dd  
(10.1, 5.8) 
3.52 dd  
(11.0, 2.8) 
 
 
3.28 dd 
(6.5, 2.3) 
3.32 m 
3.49 dd 
 (10.1, 3.5) 
3.26 t 
 (8.4) 
3.47 dd 
(11.0, 5.6) 
9-OCH3 3.36 s 3.30 s 3.27 s 3.34 s 3.24 s 3.35 s 
1’       
2’      1.51 s 
3’      1.46 s 
1 measured in CD3OD at 600 MHz (δin ppm, J in Hz); m=multiplet or overlapped  
Compound 15, [α]D -5.3, was obtained as colorless liquid. Its molecular formula was 
showed to be C11H16O3Na from an ion at m/z 219.0989 in the HRESIMS. The IR data showed 
bands for hydroxyl group (3377 cm-1) and the presence of aromatic ring (1603 and 1507 
cm-1) absorption. The 1H NMR data (table 2) showed the presence of two methoxy group at 
3.14 and 3.30 ppm, and para-substituted aromatic rings at 7.10 and 6.77 ppm as doublet (J = 
8.5 Hz) each in 5. According to (heteronuclear multiple bond conectivity) HMBC correlation 
(Fig.2) and also similarity NMR data especially on position H-7 at 4.19 ppm, 15 was 
regarded as 4-(1,3-dimethoxypropyl)phenol [58]. Zhang, et al. revealed that the related 
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compounds (3a and 3b) as R-type had [α]D positive rotations [59]. While Hodgson, D.M and 
Man. S., reported that comparable compound as S-type had specific rotation as negative value 
[60]. These findings added confidence to conclude the structure of 15 as S-type compound. 
Table 3. 13C-NMR spectroscopic data for compounds 14-191 
Position 14  15 17 18 16 19 
1 132.8 133.5 133.8 133.9 130.6 129.5 
2,6 129.4 129.0 129.1 129.4 129.8 129.2 
3,5 115.7 116.2 115.9 115.8 116.8 116.3 
4 158.2 158.2 158.0 157.9 158.5 158.8 
7 75.1 81.7 75.5 75.6 85.7 80.8 
7-OCH3  56.4   56.8  
8 64.9 38.9 76.0 75.0 75.5 83.7 
9 74.6 70.4 74.9 75.1 74.6 72.6 
9-OCH3 59.1 58.8 59.2 59.3 59.2 59.6 
1’      110.1 
2’      27.4 
3’      27.3 
1 measured in CD3OD at150 MHz (δin ppm) 
Compound 17 was isolated as colorless liquid with molecular formula C10H14O4Na 
as measured by HRESIMS at m/z 221.0785. The IR data indicated bands for hydroxyl group 
(3420 cm-1) and the presence of aromatic ring (1514 and 1455 cm-1) absorption. The 1H 
NMR data (table 2) displayed signals caused by the presence of one methoxy group at 3.27 
ppm, and an AA’BB’ type coupling system at δH 6.76 ppm (2H, d, J= 8.6 Hz) and 7.19 (2H, d, 
J= 8.4 Hz). The C-NMR data (table 3) exhibited 10 carbon peaks that were classified by 
chemical shift values and heteronuclear single quantum coherence (HSQC) spectrum (Fig.2) 
as one methoxy carbon group (δC 59.2), two sp2 methine carbons (δH 115.9 (2xC), 
129.1(2xC)), five sp2quartery carbons (δC 74.9, 76.0, 75.5, 133.8, 158.0). Mc.Elhanon, J.R., 
et al. wrote asymmetric dihydroxylation of cinnamates yielded (R, R)-diols-24 which had 
[α]D -2.70 [61]. From 1H-NMR spectrum, diol-30, 34, 35 of reference data mentioned the 
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coupling constants between H-7 and H-8 are approximately 4.5 Hz for the erythro isomer 
while 7.2 and 7.7 Hz for the threo isomer. Based on the coupling constants of H-7 and H-8 
(J= 6.6 Hz), compound 17 assigned to be the threo isomer [62]. 
Compound 18 was obtained as colorless liquid with molecular formula C10H14O4Na 
as measured by HRESIMS at m/z 221.0785. The IR data indicated bands for hydroxyl group 
(3416 cm-1) and the presence of aromatic ring (1514 and 1455 cm-1) absorption. Almost 
similar white those in diol-17, the 1H NMR data (table 2) showed peaks caused by one 
methoxy group at 3.34 ppm, and an AA’BB’ type coupling system at δH 6.76 ppm (2H, d, J = 
8.6 Hz) and 7.21(2H, d, J= 8.6 Hz). The C-NMR data (table 3) exhibited 10 carbon peaks that 
were classified by chemical shift values and heteronuclear single quantum coherence (HSQC) 
spectrum (Fig.2) as one methoxy carbon group (δC 59.3), two sp2 methine carbons (δH 115.8 
(2xC), 129.4(2xC)), five sp2quartery carbons (δC 75.0, 75.1, 75.6, 133.9, 157.9). As 
mentioned above, from 1H-NMR spectrum, diol-30, 34, 35 of reference data described the 
coupling constants between H-7 and H-8 of the erythro isomer are smaller than threo isomer 
(J less than 7.2 Hz) and the coupling constants data of H-7 and H-8 (J= 6.3 Hz), therefore 
compound 18 supposed to be reported as erythro isomer [62]. 
Compound 16, [α]D -11.6, was yielded as colorless liquid with molecular formula 
C11H16O4Na as determined by HRESIMS at m/z 235.0941. The IR data indicated bands for 
hydroxyl group (3407 cm-1) and the presence of aromatic ring (1510 and 1455 cm-1) 
absorption. From the 1H NMR data (table 2) showed peaks caused by two methoxy group at 
3.19 and 3.24 ppm, and an AA’BB’ type coupling system at δH 6.78 ppm (2H, d, J= 8.5 Hz) 
and 7.13(2H, d, J= 8.6 Hz). The 13C-NMR data (table 3) exhibited 10 carbon peaks that were 
classified by chemical shift values and heteronuclear single quantum coherence (HSQC) 
spectrum (Fig.2) as two methoxy carbons group (δC 56.8, 59.2), two sp2 methine carbons (δH 
116.8 (2xC), 129.8(2xC)), five sp2quartery carbons (δC 74.6, 75.5, 85.7, 130.6, 158.5). It has 
been reported that in the case of glycerol derivatives, the coupling constants between H-7 and 
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H-8 are approximately 5 Hz for the erythro isomer and 7 Hz for the threo isomer. Phenyl 
propanoid 16, [α]D -8.2, has been assigned as threo isomer, based on the coupling constants 
of H-7 and H-8 are 6.6 Hz [63]. Another reference mentioned that erythro isomer had been 
assigned because of the coupling constants of H-7 and H-8 are 6.3 Hz, which smaller that its 
threo isomer (J = 7.2 Hz) [64]. According to those reports, compound 16 which has the 
coupling constants of H-7 and H-8 (J=7.3 Hz), can be concluded as threo isomer. 
Compound 19, [α]D -2.4, was produced as colorless liquid with molecular formula 
C13H18O4Na as analyzed by HRESIMS at m/z 261.1099. The IR data indicated bands for 
hydroxyl group (3368 cm-1) and the presence of aromatic ring (1512 cm-1) absorption. From 
the 1H NMR data (table 2) showed peaks caused by one methoxy group at 3.35ppm, two 
methyl group at 1.46 and 1.51 ppm, and an AA’BB’ type coupling system at δH 6.79 ppm (2H, 
d, J= 8.6 Hz) and 7.21 (2H, d, J= 8.6 Hz). The 13C-NMR data (table 3) exhibited 13 carbon 
peaks that were categorized by chemical shift values and heteronuclear single quantum 
coherence (HSQC) spectrum (Fig.2) as two methyl carbons group (δC 27.3, 27.4), one 
methoxy carbons group (δC 59.6), two sp2 methine carbons (δH 116.3 (2xC), 129.2(2xC)), 
five sp2 quartery carbons (δC 72.6, 80.8, 83.7, 129.5, 158.8). It has been reported that 
acetonide protection of the 1,2-diol moiety, reduction of the ester group and hydrogenolysis 
of the benzyl ether protecting group of 24 to provide acetonide-4 (R, R), [α]D +18.0, a threo 
isomer, has coupling constants of H-7 and H-8 are 8.1 Hz [61]. The other reference also 
described that acetonide-10 (R, R), [α]D +1.0, a threo isomer, has coupling constants of H-7 
and H-8 are 8.4 Hz [63]. Morikawa, T., et al. explained acetonide-2a and acetonide-3a has 
similar NMR data, except for the coupling constants of H-7 and H-8 of acetonide-2a (J=2.8 
Hz) as erythro-form, while acetonide-3a (J=10.1 Hz) as threo-form [65]. Therefore, based on 
those literatures and NMR data, the coupling constants of H-7 and H-8 (J=8.0 Hz), phenyl 
propanoid 19, can be assigned as threo isomer. Since the specific rotation of 19 exhibited 
negative value, compound 19 must be (S,S)-isomer. 
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Figure 10. H-H COSY and H-C HMBC correlation of compound 14-19. 
2.4. Anti-parasite activity examination of Compounds 14-23. 
All isolated compounds were being investigated their activity toward promastigotes 
of L. major. Table 4 showed that 20 as the most potent against parasite of L. major. 
Compound 15, 21 and 22 also possessed substantial cytotoxicities against L. major.  
Table 4. Inhibition Rate of compounds 14-23 against L .major  
Compound IC50 (μg/mL) 1 
Cpd 14 >100  
Cpd 15 27.83 ± 0.34 
Cpd 16 70.33 ± 0.10 
Cpd 17 >100 
Cpd 18 >100 
Cpd 19 87.60 ± 1.50 
Cpd 20 0. 37 ± 1.37 
Cpd 21 51.10 ± 1.19 
Cpd 22 40.55 ± 0.95 
Cpd 23 >100 
Miltefosine 7.47 ± 0.30 
1 each value represents mean ±SE (three independent experiments). 
Cpd A (14) Cpd D (17) 
Cpd B (15) Cpd E (18) 
Cpd C (16) Cpd F (19) 
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2.5. Experimental Section  
2.5.1. General Methods 
Optical rotations were determined on a JASCO P-1030 digital polarimeter. IR spectra 
were measure on a Horiba FT-710 Fourier transform infrared spectrophotometer (Horiba, 
Kyoto, Japan), while UV spectra were taken on a Jasco V-520 UV/Vis spectrophotometer. 
NMR measurements were established on a Bruker Ultrashield 600 spectrometer with 
tetramethylsilane (TMS) as an internal standard. Positive ion HR-ESI-MS data were performed 
with a LTQ Orbitrap XL mass spectrometer. Column chromatography (CC) was carried out on 
silica gel 60 (E. Merck, Darmstadt, Germany), and octadecyl silica (ODS) gel (Cosmosil 
75C18-OPN (Nacalai Tesque, Kyoto, Japan; Φ= 35 mm, L = 350 mm). HPLC was performed 
on ODS gel (Inertsil ODS-3, GL-science, Φ=6 mm, 250 mm) and the solvent eluation was 
observed by refractive index detector. with a Jasco RI-930 intelligent detector and a Jasco 
PU-1580 intelligent pump. All chemicals were purchased from Wako Pure Chemical 
Industries, Ltd. (Osaka, Japan) and TCI (Tokyo, Japan). 
2.5.2 Preparation of Chemically Converted Extract of A. galanga and Isolation of 
Compounds 14-23 
The Rhizome of A. galanga (2.0 Kg) was extracted with MeOH (10 L) three times and 
then evaporated to give a methanolic extract (303.0 g). This residue was suspended in 1 L of 
saturated sodium carbonate solution and partitioned with ethyl acetate (1 L) three times 
producing ethyl acetate extract (68.0 g).  
To a solution of EtOAc extract (14 g) in acetonitrile (360 mL) and water (360 mL) was 
added acetone 10.35 mL, sodium bicarbonate (19.6 g) and potassium peroxosulphate (28.2 g) 
sequentially at 0°C and being stirred for 3 hours. After 3 hours, add potassium peroxosulphate 
(28.2 g) to the solution at 0°C and being stirred for another 3 hours.  The mixture continued to 
be stirred up to 24 hours. The following step was pouring into water and being extracted with 
ethyl acetate (three times). The combined organic layer was washed with water, brine and dried 
over sodium sulfate and evaporated to yield CCE of A.galanga (10.5 g).  
The CCE was separated on a silica gel (50 g) CC and eluting with increasing amount 
of MeOH in CHCl3 (20:1, 10:1, 7:1, 5:1, 3:1, 1:1, and 100% MeOH, 500 mL each), generating 
9 fractions. Fraction CCE2 (1.1 g), CCE3 (1.4 g) and CCE4 (4.0 g) were subjected to ODS CC 
with a linear gradient of 10% aq. MeOH, from 30%MeOH to 100% MeOH, (400 mL each), 
leading to eight fractions. The residue of fraction CCE 2.1 (226 mg) was purified by HPLC 
using 25% aq. acetone to give 14 (40 mg), hydroquinone (20, 100.0 mg), and 
㻌
㻌
4-hydroxy(4-hydroxyphenyl)methoxy)benzaldehyde 21 (20.0 mg). The residue of fraction 
CCE 2.2 (79.5 mg) was purified by HPLC using 30% aq. MeOH to give Isocoumarin cis 
4-hydroxymelein (22, 2.2 mg), 15 (2.4 mg), 19 (5.8 mg), and (2S, 3S, 6R, 7R, 9S, 
10S)-humulene triepoxide (23, 2.8 mg). The residue of fraction CCE 3.1 (297.5 mg) was 
purified by HPLC using 20% aq. acetone to give 20 (70.1 mg), 17 (20.1 mg), 18 (6.0 mg), and 
16 (12.5 mg). 
The chemical structures of the 14-19 and other know compounds (20-23) were 
analyzed and described through spectroscopic measurement based on IR, UV-visible, 
HR-ESI-MS data and 1D and 2D NMR, as follow. 
(erythro)-2-chloro-1-phenylpropane-1,3-diol (14) 
Colorless oil, [α]D27 -7.5 (c 1.20, MeOH); IR υmax (film) cm-1: 3350, 2935, 1668, 1607, 1454, 
1377, 1236, 1118, 1038, 850; UV λmax (MeOH) nm (log ε): 276 (3.58); 1H NMR (CD3OD, 
600 MHz) data, see Table 1 and 13C NMR (CD3OD, 151 MHz) data, see Table 2. HRESIMS 
(positive ion) m/z: 239.0446 [M+Na]+ (calcd for C10H13O3ClNa: 239.0445). 
(S)-4-(1,3-dimethoxypropyl)phenol (15) 
Colorless oil, [α]D27 -5.3 (c 0.13, MeOH); IR υmax (film) cm-1: 3377, 2927, 2857, 1701, 1603, 
1507, 1442, 1233, 1104; UV λmax (MeOH) nm (log ε): 259 (2.57); 1H NMR (CD3OD, 600 
MHz) data, see Table 1 and 13C NMR (CD3OD, 151 MHz) data, see Table 2. HRESIMS 
(positive ion) m/z: 219.0989 [M+Na]+ (calcd for C11H16O3Na: 219.0992). 
(threo)-1-(4-hydroxyphenyl)-3-methoxypropane-1,2-diol (17) 
Colorless oil, [α]D27 -4.8 (c 1.34, MeOH); IR υmax (film) cm-1: 3420, 2923, 2821, 1677, 1606, 
1514, 1455, 1240, 1119; UV λmax (MeOH) nm (log ε): 276 (2.96); 1H NMR (CD3OD, 600 
MHz) data, see Table 1 and 13C NMR (CD3OD, 151 MHz) data, see Table 2. HRESIMS 
(positive ion) m/z: 221.0785 [M+Na]+ (calcd for C10H14O4Na: 221.0784). 
(erythro)-1-(4-hydroxyphenyl)-3-methoxypropane-1,2-diol (18) 
Colorless oil, [α]D27 +6.7 (c 0.90, MeOH); IR υmax (film) cm-1: 3416, 2927, 2360, 1679, 1616, 
1514, 1455, 1240; UV λmax (MeOH) nm (log ε): 276 (2.33); 1H NMR (CD3OD, 600 MHz) 
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data, see Table 1 and 13C NMR (CD3OD, 151 MHz) data, see Table 2. HRESIMS (positive 
ion) m/z: 221.0785 [M+Na]+ (calcd for C10H14O4Na: 221.0784). 
(threo)- 4-(2-hydroxy-1,3-dimethoxypropyl)phenol (16) 
Colorless oil, [α]D27 -11.6 (c 0.86, MeOH); IR υmax (film) cm-1: 3407, 2929, 2360, 1603, 1500, 
1455, 1375; UV λmax (MeOH) nm (log ε): 279 (3.26); 1H NMR (CD3OD, 600 MHz) data, see 
Table 1 and 13C NMR (CD3OD, 151 MHz) data, see Table 2. HRESIMS (positive ion) m/z: 
235.0941 [M+Na]+ (calcd for C11H16O4Na: 235.0941). 
4-((4S,5S)-5-(methoxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)phenol 
(threo)- 4-(5-(methoxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)phenol (19)  
Colorless oil, [α]D27 -2.4 (c 0.38, MeOH); IR υmax (film) cm-1: 3368, 2986, 1732, 1607, 1512, 
1375, 1230, 1165, 1078; UV λmax (MeOH) nm (log ε): 276 (2.95); 1H NMR (CD3OD, 600 
MHz) data, see Table 1 and 13C NMR (CD3OD, 151 MHz) data, see Table 2. HRESIMS 
(positive ion) m/z: 261.1099 [M+Na]+ (calcd for C11H16O4Na: 261.1097). 
Hydroquinone (20)  
White amorphous solid, 1H-NMR (600 MHz, methanol-d4, δ): 6.63 (4H, s). 13C-NMR (151 
MHz, methanol-d4, δ): 151.1, 151.1, 116.8, 116.8, 116.8, 116.8. The obtained data are similar 
with the references [53]. 
4-hydroxy(4-hydroxyphenyl)methoxy)benzaldehyde (21) 
Colorless oil, [α]D27 -1.65 (c 1.33, MeOH); 1H-NMR (600 MHz, methanol-d4, δ): 9.76 (1H, s), 
7.78 (2H, d, J = 8.7 Hz), 7.73 (2H, m), 6.92 (2H, d, J= 8.6 Hz), 6.77 (2H, d, J= 8.6 Hz), 5.27 
(1H, s).3C-NMR (151 MHz, methanol-d4, δ): 192.9, 166.2, 158.8, 133.4, 116.9, 130.3, 104.8, 
130.5, 129.0, 115.8. HRESIMS (negative ion) m/z: 243.0661 [M-H]- (calcd for C14H11O4Na: 
243.0652). The obtained data are similar with the references [54]. 
Isocoumarin cis 4-hydroxymelein (22)  
Colorless oil, [α]D27 -6° (c = 0.15, methanol); 1H-NMR (600 MHz, methanol-d4, δ): 7.57 (1H, 
dd, J = 8.4, 7.5 Hz), 7.08 (1H, d, J = 7.5 Hz), 6.94 (1H, dd, J = 8.4, 0.7 Hz), 4.56 (1H, m), 
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4.55 (1H, m), 1.47 (3H, m). 13C-NMR (151 MHz, methanol-d4, δ): 170.2, 162.9, 144.1, 127.8, 
117.8, 117.7, 108. 0, 81.64, 69.5, 18.2. HRESIMS (negative ion) m/z: 193.0507 [M-H]- (calcd 
for C10H9O4: 193.0495). The obtained data are similar with the references [55]. 
humulene triepoxide (23) 
White amorphous solid, [α]D27 +0.5° (c = 0.19, methanol); 1H-NMR (600 MHz, methanol-d4, 
δ): 2.89 (1H, dd, J = 9.8, 5.1 Hz), 1.40 (3H, s), 2.66 (1H, dd, J = 12.9, 2.8 Hz), 0.67 (1H, m), 
2.52 (1H, d, J = 2.3 Hz), 0.87 (3H, s), 1.08 (3H, s), 1.76 (1H, dd, J = 15.2, 7.6 Hz), 1.61 (1H, d, 
J = 15.2 Hz), 2.76 (1H, d, J = 7.5 Hz), 1.38 (3H, s). 2.12 (1H, dd, J = 13.4, 5.5 Hz), 1.18 (1H, dd, 
J = 13.5, 5.7 Hz), 2.25 (1H, m), 1.15 (1H, dd, J = 13.5, 5.6 Hz). 13C-NMR (151 MHz, 
methanol-d4, δ): 60.9, 59.5, 17.2, 44.7, 54.1, 66.7, 34.2, 18.3, 29.0, 38.8, 62.9, 61.7, 16.7, 36.0, 
26.5. HRESIMS (positive ion) m/z: 252. 0890 [M+Na]+ (calcd for C15H24O3Na: 252.1726). 
The obtained data are similar with the references [56]. 
2.5.3. Anti-leishmania assay of Isolated Compounds 
The leishmanicidal activities of isolated compounds were conducted using MTT assay. 
In a 96-well micro titration plate, 1 μL of sample solutions in DMSO  and L. major cells 
(2×105 cells/well) in 99 μL medium were added to each well. Then being incubated for 72 h in 
a CO2 incubator at 25 °C. M-199 medium, supplemented with 10% heat-inactivated fetal 
bovine serum (FBS) and 100 μg/ml of kanamycin was used as the cell culture medium. After 
that, a 100 μL of MTT solution was added to each well and continued the incubation for 
another 8 hours. The absorbance of the DMSO dissolved-formazan products was recorded 
using a microplate reader at λ540 nm. The equation (1) was used to estimate % inhibition of the 
samples: 
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2.6 Extraction and Isolation of Chemically converted extract of C. heyneana 
The 1-butanol extract of C. heyneana was dissolved in DMSO (10mg/ml) then being 
heated in oil bath at 160 °C for several hours. Later on, this extract was partitioned by 
EtOAc/H2O to give the CCE of C.heyneana. The antileishmania activity of original extract and 
CCE against L. major parasite was performed by MTT assay. Fig. 11 exhibited that in the 
1-butanol extract there was some major peaks that vanished in the CCE, while in the CCE there 
was new peaks that appeared. It also showed that the inhibitory activity of CCE is majorly 
increased if compared with its original extract. The following step was bioactive compounds 
isolation using chromatographic techniques, including SiO2, ODS CC, and also HPLC  The 
elucidation structure of the isolated compounds was carried out by spectroscopy methods, 
including NMR, MS, UV, and IR spectroscopy. The chart of extraction and isolation of 
chemical constituents of C.heyneana extract as described in fig. 12: 
 
 
 
Figure 11. The Distinction of HPLC chart (left side) and Biological activity (right side) of C. heynana extracts 
before and after modification. 
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Figure 12. Extraction and isolation of CCE from C. heyneana 
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2.7 Structural Elucidation of Isolated Compounds of CCE from C. heyneana 
By using bio-guided isolation method, the CCE of C. heyneana was further isolated 
to generate a new sesquiterpene 30, along with the known compounds: Longpene A (26) [66] 
Gajustulactone A (27) [13], Gajustulactone B (28) [13], and a norlabdane-type diterpene, 
13,14,15,16 tetranorlabdan-8(17)-en-12-carboxylic acid (29) [67]. 
 
Figure 13. Isolated compounds of CCE from C. heyneana 
Compound 30 was attained as yellowish liquid. Its molecular formula was revealed 
to be C15H24O3Na from an ion at m/z 275.1612 in the HRESIMS. The IR data exhibited bands 
for hydroxyl group (3425 cm-1) and the occurrence of aromatic ring (1646 cm-1) absorption. 
The 1H NMR data (table 5) showed the presence of four methyl group at 1.16, 1.64, 1.81 and 
1.87 ppm. From 13C NMR data exhibited the existence of carbonyl group of carboxylic acid 
at 173.8 ppm, hydroxyl group at 81.2 ppm, alkenyl group at 111.3, 128.8, 142.6 and 148.7 
ppm subsequently and also methyl group at 18.7 22, 5, 23.0 and 23.3 ppm, respectively. 
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Table 5. 1H-NMR data of compound 30 
 
The 1H- 13C HMBC spectrum demonstrated correlation between H-4 with C-1, C-4, 
and C-10. The strong correlation also found between H-15 with C-10 and H-14 with C-4. The 
1H- 1H COSY spectrum displayed correlation of H-6 with H-5, H-5 with H-1 and H-1 with 
H-2. (fig. 14).  
 
 
 
 
 
 
 
Figure 14. COSY and HMBC correlation of 30 
 
 
Position 13C 1H
1 52.2 2.30 (m)
2 28.3 1.69 (m)
1.56 (m)
3 41.2 1.71 (m)
1.61 (m)
4 81.2
5 52.5 1.99 (1H, ddd, J  = 10.5, 8.0, 6.2 Hz)
6 30.3 2.40 (1H, dd, J  = 10.5, 6.2 Hz)
2.30 (m)
7 128.8
8 173.8
9 111.3 4.67 (1H, d, J =1.9 Hz )
4.60 (1H, d, J  = 2.0 Hz)
10 148.7
11 142.6
12 23.3 1.87 (3H, s)
13 22.5 1.81 (3H, s)
14 23 1.16 (3H, s)
15 18.7 1.64 (3H, s)
13C NMR and 1H NMR data (150MHz and 600 MHz, MeOD)
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From fig. 15, it showed the NOESY spectrum which exhibited the correlation 
between H-1 with H-9, H-9 with H-15, H-14 with H-6, and H-5 with H-15.  
 
Figure 15. H-H NOESYcorrelation of compound 30 
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2.8. Anti-leishmaniasis Activity Examination of Compounds 26-30 
All isolated compounds were being evaluated their inhibitory activity toward 
promastigotes of L. major. Fig. 16 displayed compound 26 and 28 possessed potential 
activity against L. major parasite, while the new compound 30 showed weak activity. Table 6 
exhibited among the isolated compounds, the highest anti leishmania activity was compound 
26 with IC50 value 46.02 ± 0.08 μg/mL. 
 
Figure 16. Biological activity of isolated compounds of CCE from C. heynana 
Table 6. Inhibition Rate of compounds 26-30 against L .major  
Isolated  
Compounds  
L. major  
IC50 (μg/mL)  
26  46.02 ±  0.08 
27 91.94 ±  2.04 
28  64.47 ±  2.25 
29  82.08 ± 4.43 
30  >100  
Miltefosine 7.47 ± 0.30  
1 each value represents mean ±SE (three independent experiments). 
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2.9. Experimental Section  
2.9.1 Preparation of Chemically Converted extract of C. heyneana and Isolation of 
Compounds 26-30 
About 17.6 g of 1-butanol extract of C. heyneana was dissolved in DMSO (10mg/ml) 
then being heated in oil bath at 160 °C for 8 hours. This extract then was extracted with 
partitioned of ethyl acetate and water. The combined organic layer was washed with water, 
brine and dried over sodium sulfate and evaporated to give the CCE of C. heyneana (15.0 g). 
The CCE was separated on a silica gel CC and eluting with MeOH/CHCl3 solvent 
producing 6 fractions. Fraction CCE1 (6.2 g) was subjected to ODS CC with a linear gradient 
of 10% aq. MeOH, from 10%MeOH to 90% MeOH, (1.5 L each), leading to nine fractions. 
The residue of fraction CCE 1.5 (500 mg) was purified by HPLC using 65% aq. acetone to give 
30. The residue of fraction CCE 1.6 (600 mg) was purified by HPLC using 65% aq. acetone to 
yield 27 and 28. The residue of fraction CCE 1.7 (1.0 g) was purified by HPLC using 65% aq. 
acetone to give 26 and 29. 
The chemical structures of the 26-30 were analyzed and described through 
spectroscopic measurement based on IR, UV-visible, HR-ESI-MS data and NMR, as follow. 
Longpene A (26) 
Colorless oil, [α]D27 +1.6° (c = 1.8, dichloromethane); 1H-NMR (600 MHz, methanol-d4, δ): δ 
6.87 (1H, t, J = 6.8 Hz), 4.96 (2H, s), 4.86 (1H, d, J = 1.1 Hz), 4.49 (1H, s), 2.58 (1H, ddd, J = 
16.5, 6.3, 2.9 Hz), 2.46 – 2.39 (2H, m), 2.06 (1H, td, J = 12.8, 4.7 Hz), 1.90 (1H, d, J = 10.8 Hz), 
1.80 – 1.75 (1H, m), 1.68 – 1.58 (1H, m), 1.57 – 1.48 (1H, m), 1.37 (1H, dd, J = 12.9, 4.2 Hz, 
1H), 1.29 – 1.11 (1H, m), 0.90 (s, 3H), 0.85 (s, 3H), 0.77 (s, 3H). 13C-NMR (151 MHz, 
methanol-d4, δ): 170.6, 149.6, 149.3, 132.1, 108.5, 58.2, 56.9, 56.6, 43.2, 40.6, 40.3, 39.0, 34.5, 
34.1, 25.4, 24.6, 22.2, 20.4, 14.9. HRESIMS (positive ion) m/z: 329. 2113 [M+Na]+ (calcd for 
C19H30O3Na: 329.2087). The obtained data are similar with the references [66]. 
Gajutsulactone A (27) 
Colorless oil, [α]D17.4 -124.9° (c = 0. 9, methanol); 1H-NMR (600 MHz, methanol-d4, δ): 4.80 
(1H, d, J = 0.5 Hz), 4.77 (1H, br.s), 2.49 (1H, dd, J = 15.9, 5.9 Hz), 2.39 – 2.31 (1H, m), 2.23 – 
2.18 (1H, m), 2.16 (3H, s), 2.08 – 2.02 (1H, m), 1.95 (1H, ddd, J = 24.3, 15.2, 7.9 Hz), 1.88 (3H, 
s), 1.86 – 1.84 (1H, m) 1.75 (3H, s), 1.74 – 1.70 (2H, m), 1.23 (3H, s).13C-NMR (151 MHz, 
methanol-d4, δ): 169.6, 154.4, 147.2, 120.8, 111.0, 86.8, 47.3, 46.9, 37.6, 27.7, 27.6, 23.7, 23.5, 
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19.6, 19.6. HRESIMS (positive ion) m/z: 235. 1695 [M+H]+ (calcd for C15H23O2: 235.1693). 
The obtained data are similar with the references [13]. 
Gajutsulactone B(28) 
Colorless oil, [α]D17.6 -41.3° (c = 0.89, methanol); 1H-NMR (600 MHz, methanol-d4, δ): 5.03 
(1H, s), 4.90 (1H, s), 2.98 – 2.93 (1H, m), 2.61 – 2.57 (1H, m), 2.32 (1H, dd, J = 10.6, 5.2 Hz), 
2.30 – 2.25 (1H, m), 2.14 (3H, s), 2.09 – 2.03 (2H, m), 1.90 (2H, t, J = 1.7 Hz), 1.89 (3H, s), 
1.81 (3H, s), 1.21 (3H, s). 13C-NMR (151 MHz, methanol-d4, δ): 169.8, 154.3, 146.7, 121.6, 
112.4, 86.9, 46.9, 43.6, 39.0, 27.1, 26.8, 25.4, 23.7, 23.4, 20.1. HRESIMS (positive ion) m/z: 
235. 1694 [M+H]+ (calcd for C15H23O2: 235.1693). The obtained data are similar with the 
references [13]. 
Tetralabdane-carboxylic acid (29) 
Colorless oil, [α]D16.1 +5.2° (c = 6.7,CHCl3); 1H-NMR (600 MHz, methanol-d4, δ): 4.92 (1H, s), 
4.76 (1H, d, J = 4.1 Hz), 4.55 (1H, d, J = 4.1 Hz), 2.49 (1H, d, J = 12.4 Hz), 2.43 – 2.38 (1H, m), 
2.32 (1H, d, J = 3.1 Hz), 2.13 – 2.05 (1H, m), 1.80 – 1.74 (1H, m), 1.67 – 1.59 (2H, m), 1.54 – 
1.47 (1H, m), 1.45 – 1.39 (1H, m), 1.36 (1H, dd, J = 12.9, 4.3 Hz), 1.24 – 1.21 (1H, m), 1.16 
(1H, m), 0.91 (3H, s), 0.85 (3H, s), 0.73 (3H, s). 13C-NMR (151 MHz, methanol-d4, δ): 177.8, 
150.4, 106.9, 56.5, 54.0, 43.2, 40.1, 39.9, 38.7, 34.4, 34.1, 31.6, 25.2, 22.2, 20.3, 14.9. 
HRESIMS (positive ion) m/z: 251. 2007 [M+Na]+ (calcd for C16H27O2Na: 251. 2006). The 
obtained data are similar with the references [67]. 
2-hydroxy-2-methyl-5-(prop-1-en-2-yl)cyclopentyl)methyl)-3-methylbut-2-enoic acid (30) 
Yellowish oil, [α]D17.9 +10.5 (c 1.5, methanol); IR υmax (film) cm-13425, 2918, 1646, 1442, 
1375, 1240, 1060; UV λmax (MeOH) nm (log ε): 223 (4.02), 202 (4.16); 1H NMR (CD3OD, 
600 MHz) and 13C NMR (CD3OD, 151 MHz) data, see Table 5. HRESIMS (positive ion) 
m/z: 275.1612 [M+Na]+ (calcd for C15H24O3Na: 275.1618). 
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